Skip to content
10-K

Annual Report

TRIMEDYNE INC

0001019687-15-000166

← back to feed
Filed
Jan 13, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Jan 14, 2015 18.4M sh
Short Term Investments FY 2014 · Sep 30, 2014 $8K
Short Term Investments FY 2014 · Sep 30, 2013 $8K
Shares Diluted FY 2014 · Sep 30, 2013 18.4M sh
Capex FY 2014 · Sep 30, 2013 $188K
Long Term Debt FY 2014 · Sep 30, 2013 $0
Current Liabilities FY 2014 · Sep 30, 2013 $703K
Total Liabilities FY 2014 · Sep 30, 2013 $714K
Current Assets FY 2014 · Sep 30, 2013 $3.41M
Total Assets FY 2014 · Sep 30, 2013 $4.7M
Eps Diluted FY 2014 · Sep 30, 2013 $0.02
Eps Basic FY 2014 · Sep 30, 2013 $0.02
Sga Expense FY 2014 · Sep 30, 2013 $2.33M
Rd Expense FY 2014 · Sep 30, 2013 $407K
Net Income FY 2014 · Sep 30, 2013 $329K
Operating Income FY 2014 · Sep 30, 2013 −$368K
Gross Profit FY 2014 · Sep 30, 2013 $2.37M
Cost Of Revenue FY 2014 · Sep 30, 2013 $3.62M
Revenue FY 2014 · Sep 30, 2013 $1.14M
Cash And Equivalents FY 2014 · Sep 30, 2012 $472K
Stockholders Equity FY 2014 · Sep 30, 2012 $3.65M